Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib

10.1016/j.addr.2004.01.012

10.1186/ar86

10.1136/ard.53.1.39

10.1002/art.1780400206

10.1002/art.1780390116

10.1007/978-3-642-56553-3_1

10.1042/bj1930469

10.1016/0076-6879(80)66528-8

10.1172/JCI115150

Turek JJ, 1993, J Cell Sci, 106, 423, 10.1242/jcs.106.1.423

10.1042/bj2910855

10.1073/pnas.88.13.5572

Antony AC, 1992, Blood, 79, 2807, 10.1182/blood.V79.11.2807.2807

Ross JF, 1994, Physiologic and clinical implications. Cancer, 732, 432

Shen F, 1995, Biochemistry, 34, 56

10.1002/1529-0131(199908)42:8<1609::AID-ANR7>3.0.CO;2-L

10.1517/17425247.5.5.499

10.1080/02652040601035143

10.1016/S0065-3233(08)60065-0

10.1016/S0065-3233(08)60640-3

10.1093/rheumatology/35.8.711

10.1016/S0928-0987(00)00169-X

10.1016/j.ijpharm.2004.08.015

Utreja S, 2001, Advances in controlled and novel drug delivery, 408

Kauper P, 2007, Eur Cel Mat, 13, 3

10.1124/dmd.31.2.224

10.1081/DDC-200037232

10.3181/00379727-111-27849